SI2683419T1 - Molekule in postopki za blokiranje in zaznavanje beljakovin - Google Patents
Molekule in postopki za blokiranje in zaznavanje beljakovinInfo
- Publication number
- SI2683419T1 SI2683419T1 SI201231316T SI201231316T SI2683419T1 SI 2683419 T1 SI2683419 T1 SI 2683419T1 SI 201231316 T SI201231316 T SI 201231316T SI 201231316 T SI201231316 T SI 201231316T SI 2683419 T1 SI2683419 T1 SI 2683419T1
- Authority
- SI
- Slovenia
- Prior art keywords
- inhibition
- proteins
- molecules
- detection
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
- C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
- C07K14/40—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts from Candida
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
- A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
- A61L29/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/08—Materials for coatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/16—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/25—Peptides having up to 20 amino acids in a defined sequence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
- C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
- C07K2319/42—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation containing a HA(hemagglutinin)-tag
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
- C07K2319/43—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation containing a FLAG-tag
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Biomedical Technology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Surgery (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Dermatology (AREA)
- Transplantation (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Ophthalmology & Optometry (AREA)
- Virology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161451855P | 2011-03-11 | 2011-03-11 | |
EP11157842 | 2011-03-11 | ||
US201161487595P | 2011-05-18 | 2011-05-18 | |
EP11176725 | 2011-08-05 | ||
PCT/EP2012/054285 WO2012123419A1 (en) | 2011-03-11 | 2012-03-12 | Molecules and methods for inhibition and detection of proteins |
EP12707813.7A EP2683419B1 (en) | 2011-03-11 | 2012-03-12 | Molecules and methods for inhibition and detection of proteins |
Publications (1)
Publication Number | Publication Date |
---|---|
SI2683419T1 true SI2683419T1 (sl) | 2018-10-30 |
Family
ID=46830069
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI201231316T SI2683419T1 (sl) | 2011-03-11 | 2012-03-12 | Molekule in postopki za blokiranje in zaznavanje beljakovin |
Country Status (12)
Country | Link |
---|---|
US (2) | US20140082769A1 (sl) |
EP (2) | EP3384939A1 (sl) |
JP (1) | JP6106101B2 (sl) |
CN (1) | CN103547296B (sl) |
AU (2) | AU2012228365A1 (sl) |
CA (1) | CA2829516C (sl) |
DK (1) | DK2683419T3 (sl) |
ES (1) | ES2679995T3 (sl) |
HR (1) | HRP20181175T1 (sl) |
LT (1) | LT2683419T (sl) |
SI (1) | SI2683419T1 (sl) |
WO (1) | WO2012123419A1 (sl) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EA030005B1 (ru) * | 2013-03-15 | 2018-06-29 | Лос-Анджелес Биомедикал Ресерч Институт Эт Харбор-Укла Медикал Центер | Композиции и способы лечения грибковых и бактериальных патогенов |
KR101890593B1 (ko) * | 2014-12-09 | 2018-08-22 | 인하대학교 산학협력단 | 병원균의 검출 및 사멸의 동시 수행이 가능한 바이오센서 및 이의 제조방법 |
KR101772642B1 (ko) * | 2015-05-27 | 2017-08-29 | 광주과학기술원 | 하이브리드 중공 마이크로캡슐, 이를 포함하는 연조직용 스캐폴드, 및 이의 제조방법 |
AU2016338586B2 (en) * | 2015-10-12 | 2021-01-28 | Amsilk Gmbh | Use of a biopolymer for reducing the formation of a biofilm |
CA3011870A1 (en) * | 2016-02-01 | 2017-08-10 | University Of Canberra | Proteinaceous compounds and uses therefor |
CN106997423B (zh) * | 2016-07-22 | 2022-03-11 | 中国药科大学 | 一种基于三维细胞模型的药物穿透动力学模型的构建及其在药物评价中的应用 |
CN106399331A (zh) * | 2016-08-31 | 2017-02-15 | 中国农业科学院植物保护研究所 | 绿盲蝽ApEps15基因及其在RNAi介导的害虫防治方面的应用 |
WO2018206732A1 (en) | 2017-05-09 | 2018-11-15 | Vib Vzw | Means and methods for treating bacterial infections |
US20210171907A1 (en) | 2017-12-05 | 2021-06-10 | Celyad S.A. | Compositions and methods for improving persistence of cells for adoptive transfer |
CN112218943A (zh) | 2017-12-05 | 2021-01-12 | 塞利亚德股份公司 | 减少表达基于nkg2d的受体的免疫细胞的杀伤剂 |
CN108118019A (zh) * | 2018-03-09 | 2018-06-05 | 易虹 | 枯草芽孢杆菌菌株及其应用 |
US11541105B2 (en) | 2018-06-01 | 2023-01-03 | The Research Foundation For The State University Of New York | Compositions and methods for disrupting biofilm formation and maintenance |
CN118620926A (zh) * | 2019-04-08 | 2024-09-10 | Dna2.0股份有限公司 | 使用来自螟蛾属的转座酶将核酸构建体转座入真核基因组 |
US11003908B2 (en) * | 2019-07-23 | 2021-05-11 | Regents Of The University Of Minnesota | Remote-sensing-based detection of soybean aphid induced stress in soybean |
CN110964096B (zh) * | 2019-12-27 | 2023-04-21 | 润方(长春)生物科技有限公司 | 一种重组人源c反应蛋白的制备方法 |
CA3170658A1 (en) | 2020-02-19 | 2021-08-26 | Aelin Therapeutics | Molecules targeting mutant ras protein |
KR20220143730A (ko) | 2020-02-19 | 2022-10-25 | 에린 테라퓨틱스 | 단백질을 표적화하는 분자 |
US20230207075A1 (en) * | 2020-05-19 | 2023-06-29 | Nucleus Biologics | Media formulations and production |
CN114057858B (zh) * | 2020-08-10 | 2023-03-21 | 上海瑞吉康生物医药有限公司 | 对引起神经变性和神经退行性疾病的蛋白聚集具有解聚作用的多肽 |
CN112111000B (zh) * | 2020-09-30 | 2024-03-19 | 南京基蛋生物医药有限公司 | 一种诊断试剂用重组蛋白的制备方法及其应用 |
US20230349904A1 (en) * | 2020-10-06 | 2023-11-02 | The Regents Of The University Of California | Methods for detecting antibodies |
CN112655584A (zh) * | 2020-12-22 | 2021-04-16 | 江苏瞪羚科技有限公司 | 一种高性能的宠物用消毒装置 |
CN112715489B (zh) * | 2020-12-30 | 2022-05-13 | 贵州大学 | 一种白条菌瓢虫的饲养方法 |
CA3212298A1 (en) | 2021-03-03 | 2022-09-09 | Vib Vzw | Beta-lactamase inhibitors |
CN115825173A (zh) * | 2021-09-18 | 2023-03-21 | 艾康生物技术(杭州)有限公司 | 一种质控液及其应用 |
CN114047338B (zh) * | 2021-11-10 | 2024-03-12 | 上海捷门生物技术有限公司 | 一种尿液转铁蛋白检测试剂盒及其检测方法 |
CN115820686B (zh) * | 2022-08-22 | 2023-09-12 | 西南大学 | 一种柑橘CsGSTU18基因及其应用 |
Family Cites Families (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4478946A (en) | 1981-07-02 | 1984-10-23 | South African Inventions Development Corporation | Carrier bound immunosorbent |
US4550017A (en) | 1982-10-15 | 1985-10-29 | Syntex (U.S.A.) Inc. | Fluorescence screening for blood typing |
US5023252A (en) | 1985-12-04 | 1991-06-11 | Conrex Pharmaceutical Corporation | Transdermal and trans-membrane delivery of drugs |
US5011472A (en) | 1988-09-06 | 1991-04-30 | Brown University Research Foundation | Implantable delivery system for biological factors |
US6159748A (en) | 1995-03-13 | 2000-12-12 | Affinitech, Ltd | Evaluation of autoimmune diseases using a multiple parameter latex bead suspension and flow cytometry |
ES2260809T3 (es) | 1997-07-01 | 2006-11-01 | Vlp Watertown Limited Partnership | Metodo para la determinacion del sexo de una progenie mamifera. |
US6399317B1 (en) | 1998-04-15 | 2002-06-04 | Utah State University | Real time detection of antigens |
US6294349B1 (en) | 1999-03-01 | 2001-09-25 | University Of Mississippi Medical Ctr. | Method of diagnosing and monitoring malignant breast carcinomas |
US6682940B2 (en) | 1999-05-04 | 2004-01-27 | Dan A. Pankowsky | Products and methods for single parameter and multiparameter phenotyping of cells |
CA2366104C (en) | 1999-07-22 | 2010-07-06 | Japan As Represented By Director General Of National Institute Of Agrobiological Resources, Ministry Of Agriculture, Forestry And Fisheries | Ultra-fast transformation technique for monocotyledons |
WO2001083058A2 (en) | 2000-05-01 | 2001-11-08 | Cfph, L.L.C. | Real-time interactive wagering on event outcomes |
AU2003235749A1 (en) | 2002-01-07 | 2003-07-24 | John Hopkins University | Biomarkers for detecting ovarian cancer |
US20060088894A1 (en) | 2002-05-10 | 2006-04-27 | Eastern Virginia Medical School | Prostate cancer biomarkers |
EP1506408A4 (en) | 2002-05-17 | 2007-07-11 | Eastern Virginia Med School | METHOD FOR DIAGNOSIS OF HTLV-I-MEDIATED DISEASES |
WO2004043444A1 (en) | 2002-11-06 | 2004-05-27 | Mount Sinai School Of Medicine | Treatment of amyotrophic lateral sclerosis with nimesulide |
DE10330758B4 (de) | 2003-07-07 | 2006-07-20 | Sirona Dental Systems Gmbh | Rohling zur Herstellung zahntechnischer Formteile und Verfahren zur Herstellung des Formteils |
JP2007502990A (ja) | 2003-08-19 | 2007-02-15 | イースタン バージニア メディカル スクール | 頭頸部扁平上皮癌を診断するための方法 |
US20050158745A1 (en) | 2003-11-25 | 2005-07-21 | Ye Jack Z. | Methods and compositions for detection of nasopharyngeal carcinoma |
US20050202485A1 (en) | 2004-03-03 | 2005-09-15 | Ye Jack Z. | Method and compositions for detection of liver cancer |
WO2005098445A2 (en) | 2004-03-30 | 2005-10-20 | Eastern Virginia Medical School | Lung cancer biomarkers |
CA2578670C (en) | 2004-04-15 | 2017-03-07 | University Of Florida Research Foundation, Inc. | Neural proteins as biomarkers for nervous system injury and other neural disorders |
US20060029980A1 (en) | 2004-08-09 | 2006-02-09 | David Gozal | Method for diagnosing obstructive sleep apnea |
EP1927597B1 (en) | 2004-08-18 | 2016-11-02 | Novabiotics Limited | Antibacterial peptides |
WO2006060799A2 (en) | 2004-12-02 | 2006-06-08 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Protein biomarkers and therapeutic targets in an animal model for amyotrophic lateral sclerosis |
GB0524190D0 (en) | 2005-11-28 | 2006-01-04 | Helse Stavanger Hf | Method |
GB0525049D0 (en) | 2005-12-08 | 2006-01-18 | Biowisdom Ltd | A method of detecting skeletal muscle damage |
JP5888832B2 (ja) * | 2005-12-22 | 2016-03-22 | フラームス・インテルウニフェルシタイル・インステイチュート・フォール・ビオテヒノロヒー・ヴェーゼットウェー(ヴェーイーベー・ヴェーゼットウェー)Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw(Vib Vzw) | タンパク質干渉を媒介する手段および方法 |
CA2632331C (en) * | 2005-12-22 | 2015-02-10 | Vib Vzw | Molecules with a beta-aggregating region and their use in inducing protein aggregation |
WO2008140463A2 (en) | 2006-06-12 | 2008-11-20 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Biomarker panels for assessing radiation injury and exposure |
JP5322108B2 (ja) * | 2006-07-10 | 2013-10-23 | ペーベーアードライ ビオメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング | 抗菌ペプチド |
US7851172B2 (en) | 2006-07-25 | 2010-12-14 | University Of Kentucky Research Foundation | Biomarkers of mild cognitive impairment and alzheimer's disease |
DK2162461T3 (en) * | 2007-06-04 | 2017-07-10 | Vib Vzw | TARGETED INDUCTION OF AGGREGATION OF PROTEINS WITH CROSS-BETA STRUCTURES |
WO2009039023A2 (en) | 2007-09-18 | 2009-03-26 | Board Of Regents Of The University Of Texas System | Detection of saliva proteins modulated secondary to ductal carcinoma in situ of the breast |
WO2009046267A1 (en) | 2007-10-05 | 2009-04-09 | University Of Virginia Patent Foundation | Protein-based biomarkers for abdominal aortic aneurysm |
WO2009055820A2 (en) | 2007-10-26 | 2009-04-30 | The Regents Of The University Of California | Salivary protein biomarkers for human oral cancer |
EP2223119B1 (en) | 2007-11-16 | 2014-09-10 | Biocartis NV | Biomarkers and methods for diagnosing, predicting and/or prognosing sepsis and uses thereof |
US20120270233A1 (en) | 2008-02-11 | 2012-10-25 | Historx, Inc. | Association of biomarkers with patient outcome |
EP2304434A2 (en) | 2008-06-04 | 2011-04-06 | ProteoSys AG | Protein biomarkers for in vitro testing of developmental toxicity and embryotoxicity of chemical substances |
WO2010033993A2 (en) | 2008-09-22 | 2010-03-25 | Historx, Inc. | Correlation of molecular markers with clinical outcome in gbm patients radiation treated with or without gefitinib |
US8962341B2 (en) | 2008-12-12 | 2015-02-24 | The Commonwealth Medical College | Cell-based detection of APF through its interaction with CKAP4 for diagnosis of interstitial cystitis |
SG10201401054YA (en) * | 2008-12-29 | 2014-07-30 | Tel Hashomer Medical Res Infrastructure & Services Ltd | Peptides and compositions for prevention of cell adhesion and methods of using same |
WO2010078403A2 (en) | 2008-12-30 | 2010-07-08 | Lipella Pharmaceuticals Inc. | Methods and compositions for diagnosing urological disorders |
KR20110110247A (ko) | 2008-12-30 | 2011-10-06 | 센토코 오르토 바이오테크 인코포레이티드 | 강직성 척추염 환자에서 항-TNFα 항체에 대한 임상적 반응을 예측하는 혈청 마커 |
AU2010203698B2 (en) * | 2009-01-06 | 2016-07-21 | C3 Jian, Inc. | Targeted antimicrobial moieties |
WO2010093869A1 (en) | 2009-02-12 | 2010-08-19 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for monitoring allograft rejection |
WO2010115077A2 (en) | 2009-04-02 | 2010-10-07 | The Johns Hopkins University | Biomarker panels for barrett's esophagus and esophageal adenocarcinoma |
WO2010113185A1 (en) | 2009-04-03 | 2010-10-07 | Decode Genetics Ehf | Genetic markers for risk management of atrial fibrillation and stroke |
TW201100801A (en) | 2009-06-18 | 2011-01-01 | Atomic Energy Council | Serum biomarkers and the testing methods for diagnosing liver fibrosis |
US20120178100A1 (en) | 2009-07-28 | 2012-07-12 | Centocor Ortho Biotech Inc. | Serum Markers Predicting Clinical Response to Anti-TNF Alpha Antibodies in Patients with Psoriatic Arthritis |
-
2012
- 2012-03-12 JP JP2013557135A patent/JP6106101B2/ja active Active
- 2012-03-12 EP EP18171179.7A patent/EP3384939A1/en not_active Withdrawn
- 2012-03-12 LT LTEP12707813.7T patent/LT2683419T/lt unknown
- 2012-03-12 EP EP12707813.7A patent/EP2683419B1/en active Active
- 2012-03-12 DK DK12707813.7T patent/DK2683419T3/en active
- 2012-03-12 CN CN201280022434.0A patent/CN103547296B/zh active Active
- 2012-03-12 AU AU2012228365A patent/AU2012228365A1/en not_active Abandoned
- 2012-03-12 WO PCT/EP2012/054285 patent/WO2012123419A1/en active Application Filing
- 2012-03-12 CA CA2829516A patent/CA2829516C/en active Active
- 2012-03-12 ES ES12707813.7T patent/ES2679995T3/es active Active
- 2012-03-12 US US14/004,042 patent/US20140082769A1/en not_active Abandoned
- 2012-03-12 SI SI201231316T patent/SI2683419T1/sl unknown
-
2017
- 2017-01-24 AU AU2017200470A patent/AU2017200470B2/en not_active Ceased
-
2018
- 2018-07-25 HR HRP20181175TT patent/HRP20181175T1/hr unknown
-
2021
- 2021-08-13 US US17/402,016 patent/US20220033448A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
CA2829516A1 (en) | 2012-09-20 |
EP2683419A1 (en) | 2014-01-15 |
HRP20181175T1 (hr) | 2018-09-21 |
JP6106101B2 (ja) | 2017-03-29 |
WO2012123419A1 (en) | 2012-09-20 |
CA2829516C (en) | 2020-08-18 |
CN103547296B (zh) | 2016-08-17 |
EP3384939A1 (en) | 2018-10-10 |
JP2014514917A (ja) | 2014-06-26 |
EP2683419B1 (en) | 2018-05-09 |
US20220033448A1 (en) | 2022-02-03 |
ES2679995T3 (es) | 2018-09-03 |
DK2683419T3 (en) | 2018-07-02 |
US20140082769A1 (en) | 2014-03-20 |
AU2017200470A1 (en) | 2017-02-16 |
AU2012228365A1 (en) | 2013-09-19 |
LT2683419T (lt) | 2018-07-25 |
AU2017200470B2 (en) | 2019-07-11 |
CN103547296A (zh) | 2014-01-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20181175T1 (hr) | Molekule i postupci za inhibiciju i otkrivanje proteina | |
HK1252237A1 (zh) | 用於分子或粒子的超靈敏探測的系統、裝置以及方法 | |
HK1199892A1 (en) | Modified mini-hepcidin peptides and methods of using thereof | |
HK1245890A1 (zh) | 用於微生物檢測的方法和系統 | |
HK1200037A1 (en) | Non-invasive methods of detecting target molecules | |
GB2507231B (en) | Methods for Detection of Cytosine Modification | |
HK1206065A1 (en) | Compositions and methods for analyte detection | |
GB2493391B (en) | Optical detection and analysis of particles | |
EP2794907A4 (en) | METHODS AND MATERIALS FOR EVALUATING LOSS OF HETEROZYGOTIA | |
EP2663857A4 (en) | METHOD OF DETECTION OF PROTEINS | |
EP2751573A4 (en) | SYSTEM AND METHOD FOR DETECTING ALLERGENS | |
ZA201303377B (en) | System and method for detection of minefileds | |
GB201120965D0 (en) | System and method for detection of analytes | |
FI20115701A (fi) | Järjestely ja menetelmä jäätymisen havainnoimiseksi | |
EP2791361A4 (en) | METHODS AND KITS FOR DETECTION OF METHYLATION CONDITION | |
EP2710119A4 (en) | COMPOSITION AND METHODS FOR INHIBITION OF JAMM PROTEINS | |
HK1204016A1 (en) | Methods and kits for detecting subjects at risk of having cancer | |
GB2507681B (en) | Detection of pipeline contaminants | |
EP2674911A4 (en) | SYSTEM FOR THE DETECTION OF DIFFERENT REGIONS AND METHOD FOR THE DETECTION OF DIFFERENT REGIONS | |
EP2726652A4 (en) | PROCESS FOR PROTEIN DISPLAY | |
EP2692869A4 (en) | DETECTION PROCESS FOR NUCLEIC ACID AND KIT AND ITS USE | |
EP2753359A4 (en) | SERPINF2 BINDEMOLEKÜLE AND METHOD FOR THEIR USE | |
EP2805281A4 (en) | METHOD FOR ILLUSTRATING LINEAR MOLECULES FOR DETECTING STRUCTURE VARIATIONS AND SEQUENCING | |
EP2780930A4 (en) | METHOD AND APPARATUS FOR DETERMINING THE PROPERTIES OF GASEOUS PHASE BASES OR ACIDS | |
EP2753708A4 (en) | SYSTEMS AND METHODS FOR BIOSIMILARITY ASSESSMENT |